Further studies on NfM, especially in FTD and AD with larger patient cohorts, as well as investigations of NfM in neuroinflammatory diseases and in longitudinal studies will provide more insight into its potential value for the (differential-) diagnosis and monitoring of neurological diseases. This evidence concerns the gene NEFM and Alzheimer disease.